$Microsoft (MSFT.US)$ I know you people are trying to use "regular investor guy" mentality to justify the CEO selling ½ his shares, but a CEO is not a regular guy. It shows a lack of confidence in his company and his management to sell that much all at once. Selling now to avoid paying a 7% tax later means he doesn't think the stock will go up 7% in the next year. It also lacks class, since that kind of money is just a scorecard. You don't actually spend it. So talking about tax management like you're some kind of regular guy who's saving up to buy a house is silly. He chose to sell shares because he could see that the price today is higher than it will be in the future. This is terrible optics and is a clear sign that something bad is coming. A CEO has a pretty good idea what business looks like for the next 12 months & this is a huge sell signal. Invest if you want, but don't say I didn't warn you.

Despite a threat to vaccine-driven immunity with the recent emergence of the new COVID-19 variant Omicron, $Pfizer (PFE.US)$ is on course to record its best monthly gain since Dec. 1991.
Over the past 12 months, the shares of the New York-based pharma giant has climbed ~40.8% well outperforming the broader index, as indicated in the graph below. Driven by the sales of the vaccine it co-developed with $BioNTech (BNTX.US)$ , its revenue has more than doubled over the past year.
Pfizer’s performance contrasts with rival vaccine maker $Moderna (MRNA.US)$ whose CEO has warned that the COVID-19 vaccines could lose efficacy against Omicron, classified by the World Health Organization (WHO) as a global variant of concern.
However, Pfizer targets both preventative and therapeutic aspects of the disease with its vaccine and the experimental COVID-19 pill Paxlovid, for which the company has already sought U.S. regulatory authorization.

Any further down, I'd buy  $Tesla (TSLA.US)$

$Amazon (AMZN.US)$ Waiting you go up